Evidence Intelligence for Diabetes

Organizing diabetes research into clear, evidence-based insights powered by the Evidence Intelligence™ framework.

Understand diabetes research—without reading every study

Evidence Intelligence
370
Studies Analyzed
1,997
Evidence Relationships
266
Interventions Tracked
773
Outcomes Modeled
Evidence Comparison Preview
Top-ranked evidence relationships
Semaglutide
HbA1c
EvidenceScore™ 87
Metformin
HbA1c
EvidenceScore™ 85
Tirzepatide
HbA1c
EvidenceScore™ 85

Explore Diabetes Evidence Topics

Deep dives into key evidence areas with comprehensive research synthesis

How Diabetes Evidence Connects

Every study contributes evidence linking interventions and outcomes. deDiabetes organizes those findings into connected evidence topics so you can move from broad questions to supporting research.

Intervention
Physical Activity
Outcome
HbA1c Reduction
Intervention
Metformin
Outcome
Glycemic Control
Intervention
CGM
Outcome
Time in Range
266
Interventions
773
Outcomes
1,997
Evidence Relationships
connected findings

Featured Evidence Insights

Strongest findings from our evidence intelligence analysis

Grouped evidence
Detailed evidence

GLP-1 Receptor Agonists → Body Weight

Semaglutide → Body weight

Semaglutide shows moderate improvement in Body weight with consistent results (well-studied, 10 studies).

Evidence Intelligence™
ImpactScore™
84
Positive
EvidenceScore™
86
Strong
ConsistencyScore™
96
consistent
Supporting studies: Based on 10 studies
View evidence
Grouped evidence
Detailed evidence

GLP-1 Receptor Agonists → HbA1c

Semaglutide → HbA1c

Semaglutide shows strong improvement in HbA1c with consistent results (well-studied, 11 studies).

Evidence Intelligence™
ImpactScore™
92
Very Positive
EvidenceScore™
86
Strong
ConsistencyScore™
92
consistent
Supporting studies: Based on 11 studies
View evidence
Grouped evidence
Detailed evidence

GLP-1 Receptor Agonists → HbA1c

Tirzepatide → HbA1c

Tirzepatide shows strong improvement in HbA1c with consistent results (well-studied, 9 studies).

Evidence Intelligence™
ImpactScore™
92
Very Positive
EvidenceScore™
86
Strong
ConsistencyScore™
92
consistent
Supporting studies: Based on 9 studies
View evidence
Grouped evidence
Detailed evidence

Metformin Therapies → HbA1c

Metformin → HbA1c

Metformin shows moderate improvement in HbA1c with consistent results (emerging research, 7 studies).

Evidence Intelligence™
ImpactScore™
83
Positive
EvidenceScore™
88
Strong
ConsistencyScore™
86
consistent
Supporting studies: Based on 7 studies
View evidence
Grouped evidence
Detailed evidence

GLP-1 Receptor Agonists → Body Weight

Tirzepatide → Body weight

Tirzepatide shows strong improvement in Body weight with consistent results (emerging research, 8 studies).

Evidence Intelligence™
ImpactScore™
84
Positive
EvidenceScore™
86
Strong
ConsistencyScore™
96
consistent
Supporting studies: Based on 8 studies
View evidence
Grouped evidence
Detailed evidence

GLP-1 Receptor Agonists → Body Weight

Liraglutide → Body weight

Liraglutide shows moderate improvement in Body weight with consistent results (emerging research, 4 studies).

Evidence Intelligence™
ImpactScore™
84
Positive
EvidenceScore™
86
Strong
ConsistencyScore™
96
consistent
Supporting studies: Based on 4 studies
View evidence

Evidence Collections

High-value evidence organized by ImpactScore™, EvidenceScore™, ConsistencyScore™, and research focus

Latest Updates

View all →

Recently added studies and evidence pairs

Evidence Comparison Table

Highest-ranked intervention and outcome relationships from the evidence graph

Ranked using EvidenceScore™, validation, ConsistencyScore™, and study depth

#1
Semaglutide
HbA1c
strong_positiveEvidenceScore™87
0 studies
#2
Semaglutide
Body weight
moderate_positiveEvidenceScore™87
0 studies
#3
Metformin
HbA1c
moderate_positiveEvidenceScore™85
0 studies
#4
Tirzepatide
HbA1c
strong_positiveEvidenceScore™85
0 studies
#5
Tirzepatide
Body weight
strong_positiveEvidenceScore™84
0 studies
#6
SMS text messaging behavioral intervention for health promotion
HbA1c
weak_positiveEvidenceScore™83
0 studies
#7
Vitamin D supplementation
HbA1c
moderate_positiveEvidenceScore™82
0 studies
#8
Dapagliflozin
HbA1c
moderate_positiveEvidenceScore™81
0 studies
#9
Semaglutide
BMI
moderate_positiveEvidenceScore™79
0 studies
#10
Liraglutide
Body weight
moderate_positiveEvidenceScore™79
0 studies
#11
Hybrid closed-loop system
HbA1c
strong_positiveEvidenceScore™74
0 studies
#12
Hybrid closed-loop system
Time in range
strong_positiveEvidenceScore™69
0 studies

How to Read Evidence Cards

Understanding an Evidence Card

Every Evidence Card summarizes one intervention-outcome relationship using Dediabetes' Evidence Intelligence system: ImpactScore™, EvidenceScore™, ConsistencyScore™, supporting study count, and direct access to the underlying evidence.

Example Evidence Card

GLP-1 receptor agonists → HbA1c

Current evidence suggests a positive impact on HbA1c with strong supporting evidence and generally consistent findings across studies.

Evidence Intelligence™
ImpactScore™
82
Positive
EvidenceScore™
70
Moderate
ConsistencyScore™
89
Consistent
Supporting studies: Based on 11 studies
View evidence
1

Relationship

Intervention → Outcome. The evidence relationship being summarized.

2

Evidence Summary

A plain-language summary of what the evidence suggests.

3

ImpactScore™

ImpactScore™ summarizes what impact the current evidence suggests.

4

EvidenceScore™

EvidenceScore™ summarizes how much confidence to place in that conclusion.

5

ConsistencyScore™

ConsistencyScore™ summarizes how consistently independent studies reach the same conclusion.

6

Supporting Studies

Number of studies contributing to this evidence relationship.

7

Call to Action

Open the full evidence page for supporting studies, methodology, and related evidence.

ImpactScore™, EvidenceScore™, and ConsistencyScore™ are generated by the Evidence Intelligence system and are not medical advice.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.